CCR2 Composition for preventing or treating bone diseases comprising CCR2

摘要

The present invention relates to a pharmaceutical composition for the prevention or treatment of bone diseases comprising a CCR2 (CC chemokine receptor type 2) protein or a polynucleotide encoding the CCR2 protein as an active ingredient, and is used for the prevention or treatment of bone diseases such as osteoarthritis. It can be useful.